Kenchappa Divya B, Korolkova Olga, Sakwe Nobelle, Odiase Peace, Izban Michael G, Sakwe Amos, Ochieng Josiah
Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 Dr. D.B. Todd Blvd., Nashville, TN 37208.
Present Address: Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461.
J Pharm Pharmacol Res. 2025;9(1):1-9. doi: 10.26502/fjppr.0103. Epub 2025 Feb 4.
The present studies were undertaken to address the innovative role of fetuin-A in the growth and invasion potential in a triple negative breast cancer (TNBC) cell line, MDA-MB-468. Basal like TNBC that express high levels of ectopic fetuin-A have poorer prognosis for the patients compared to those that express low levels of the protein. We overexpressed fetuin-A in MDA-MB-468 and then determined the invasive potential of fetuin-A overexpressing cells vs controls transfected with empty vector. We also determined the adhesion and growth potential of the cells in the presence of only fetuin-A in serum free medium and also in complete medium. Our data suggest that fetuin-A overexpression significantly enhances the invasive potential of the cells and also the expression of Toll like receptor 4 (TLR4) on these cells. More importantly, the cells rely on fetuin-A-TLR4 signaling network for growth and invasion because the specific TLR4 inhibitor CLI-095 (resatorvid) abrogates fetuin-A mediated growth and invasion. Taken together, the data suggest that fetuin-A-TLR4 signaling network plays a significant role in the growth and invasion potential of TNBC.
本研究旨在探讨胎球蛋白-A在三阴性乳腺癌(TNBC)细胞系MDA-MB-468的生长和侵袭潜能中的创新作用。与那些低水平表达该蛋白的患者相比,表达高水平异位胎球蛋白-A的基底样TNBC患者预后较差。我们在MDA-MB-468中过表达胎球蛋白-A,然后确定过表达胎球蛋白-A的细胞与用空载体转染的对照细胞的侵袭潜能。我们还测定了在无血清培养基中仅存在胎球蛋白-A时以及在完全培养基中细胞的黏附及生长潜能。我们的数据表明,胎球蛋白-A的过表达显著增强了细胞的侵袭潜能以及这些细胞上Toll样受体4(TLR4)的表达。更重要的是,细胞依赖胎球蛋白-A-TLR4信号网络进行生长和侵袭,因为特异性TLR4抑制剂CLI-095(瑞斯托霉素)消除了胎球蛋白-A介导的生长和侵袭。综上所述,数据表明胎球蛋白-A-TLR4信号网络在TNBC的生长和侵袭潜能中起重要作用。